An antiviral disulfide compound blocks interaction between arenavirus Z protein and cellular promyelocytic leukemia protein

Biochemical and Biophysical Research Communications

Volumn 393, Issue 4, 2010, Pages 625-630

  Garcia C C ^a   Topisirovic, I ^b   Djavani, M ^c   Borden, K L B ^b   Damonte, E B ^a   Salvato, M S ^c  

^a Laboratorio de Virologia Ciudad Autonoma de Buenos Aires   (Argentina)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antiviral disulfide agent; Arenavirus; Lymphocytic choriomeningitis virus; Promyelocytic leukemia protein; RING finger interactions; Z protein

Indexed keywords

ANTIVIRUS AGENT; ARENAVIRUS Z PROTEIN; DISULFIDE; MUTANT PROTEIN; NSC 20625; PROMYELOCYTIC LEUKEMIA PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CELL NUCLEUS INCLUSION BODY; CELL STRAIN HEPG2; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

ANTIVIRAL AGENTS; ARENAVIRIDAE INFECTIONS; CARRIER PROTEINS; CELL LINE; DISULFIDES; GUANIDINES; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

ARENAVIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 77949484723     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.040     Document Type: Article

References (38)

1. Barton L., Peters C., and Ksiazek T. Lymphocytic choriomeningitis virus: an unrecognized teratogenic pathogen. Emerg. Infect. Dis. 1 (1995) 152-153
2. Barton L., and Hyndman N. Lymphocytic choriomeningitis virus: reemerging central nervous system pathogen. Pediatrics 105 (2000) 35-36
3. N. Hannachia, F. Freymuthb, D. Lutonc, M. Herlicoviezd, J.-F. Ourye, J. Boukadidaf, P. Lebona, Infection par le virus de la chorioméningite lymphocytaire et fœtopathies, Pathol. Biol. doi:10.1016/j.patbio.2009.06.001.
4. Fischer S., Graham M., Kuehnert M., Kotton C., Srinivasan A., Marty F., Comer J., Guarner J., Paddock C., DeMeo D., Shieh W., Erickson B., Bandy U., DeMaria Jr. A., Davis J., Delmonico F., Pavlin B., Likos A., Vincent M., Sealy T., Goldsmith C., Jernigan D., Rollin P., Packard M., Patel M., Rowland C., Helfand R., Nichol S., Fishman J., Ksiazek T., and Zaki S. LCMV in transplant recipients investigation team. New Engl. J. Med. 354 (2006) 2235-2249
5. Garcin D., Rochat S., and Kolakofsky D. The Tacaribe arenavirus small zinc finger protein is required for both mRNA synthesis and genome replication. J. Virol. 67 (1993) 807-812
6. Cornu T., and de la Torre J. RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome. J. Virol. 75 (2001) 9415-9426
7. López N., Jácamo R., and Franze-Fernández M. Transcription and RNA replication of Tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes. J. Virol. 75 (2001) 12241-12251
8. Cornu T., and de la Torre J. Characterization of the arenavirus RING finger Z protein regions required for Z-mediated inhibition of viral RNA synthesis. J. Virol. 76 (2002) 6678-6688
9. Salvato M., Schweighofer K., Burns J., and Shimomaye E. Biochemical and immunological evidence that the 11 kDa zinc-binding protein of lymphocytic choriomeningitis virus is a structural component of the virus. Virus Res. 22 (1992) 185-198
10. Perez M., Craven R., and de la Torre J. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc. Natl. Acad. Sci. USA 100 (2003) 12978-12983
11. Strecker T., Eichler R., ter Meulen J., Weissenhorn W., Klenk H., Garten W., and Lenz O. Lassa virus Z protein is a matrix protein sufficient for the release of virus-like particles. J. Virol. 77 (2003) 10700-10705
12. Neuman B., Adair B., Burns J., Milligan R., Buchmeier M., and Yeager M. Complementarity in the supramolecular design of arenaviruses and retroviruses revealed by electron cryomicroscopy and image analysis. J. Virol. 79 (2005) 3822-3830
13. Franze-Fernández M., Iapalucci S., López N., and Rossi C. Subgenomic RNAs of Tacaribe virus. In: Salvato M.S. (Ed). The Arenaviridae (1993), Plenum, New York 113-132
14. Perez M., Greenwald D., and de la Torre J.. Myristoylation of the RING finger Z protein is essential for arenavirus budding. J. Virol. 78 (2004) 11443-11448
15. Freed E. Viral late domains. J. Virol. 76 (2002) 4679-4687
16. Eichler R., Strecker T., Kolesnikova L., ter Meulen J., Weissenhorn W., Becker S., Klenk H., Garten W., and Lenz O. Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res. 100 (2004) 249-255
17. Urata S., Yasuda J., and de la Torre J.C. The Z protein of the New World arenavirus Tacaribe virus has bona fide budding activity that does not depend on known late domain motifs. J. Virol. 83 (2009) 12651-12655
18. Borden K., Campbell Dwyer E., and Salvato M. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J. Virol. 72 (1998) 758-766
19. Borden K., Campbell Dwyer E., Carlile G., Djavani M., and Salvato M. Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins. J. Virol. 72 (1998) 3819-3826
20. Campbell Dwyer E., Lai H., MacDonald R., Salvato M., and Borden K. The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner. J. Virol. 74 (2000) 3293-3300
21. Djavani M., Topisirovic I., Zapata J., Sadowska M., Yang Y., Rodas J., Lukashevich I., Bogue C., Pauza C., Borden K., and Salvato M. The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virus. J. Virol. 79 (2005) 2461-2473
22. García C., Candurra N., and Damonte E. Antiviral and virucidal activities against arenaviruses of zinc-finger active compounds. Antiviral Chem. Chemother. 11 (2000) 231-238
23. García C., Djavani M., Topisirovic I., Borden K., Salvato M., and Damonte E. Arenavirus Z protein as an antiviral target: virus inactivation and protein oligomerization by zinc finger-reactive compounds. J. Gen. Virol. 87 (2006) 1217-1228
24. Borden K., Campbell Dwyer E., and Salvato M. The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain. FEBS Lett. 418 (1997) 30-34
25. Borden K., and Freemont P. The RING finger: an example of a sequence structure family. Curr. Opin. Struc. Biol. 6 (1996) 395-401
26. Tortorici M., Ghiringhelli P., Lozano M., Albarino C., and Romanowski V. Zinc-binding properties of Junin virus nucleocapsid protein. J. Gen. Virol. 82 (2001) 121-128
27. York J., and Nunberg J. A novel zinc-binding domain is essential for formation of the functional Junín virus envelope glycoprotein complex. J. Virol. 81 (2007) 13385-13391
28. Lukashevich I., Tikhonov I., Rodas J., Zapata J., Yang Y., Djavani M., and Salvato M. Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation. J. Virol. 77 (2003) 1727-1737
29. Nemeth E., Baird A., and O'Farrelly C. Microanatomy of the liver immune system. Semin. Immunopathol. 31 (2009) 333-343
30. Barber G. Host defense, viruses and apoptosis. Cell. Death Differ. 8 (2001) 113-126
31. Whitton J., Cornell C., and Feuer R. Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 3 (2005) 765-776
32. Bernardi R., and Pandolfi P. Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22 (2003) 9048-9057
33. Hofmann T., and Will H. Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ. 10 (2003) 1290-1299
34. Takahashi Y., Lallemand-Breitenbach V., Zhu J., and de The H. PML nuclear bodies and apoptosis. Oncogene 23 (2004) 2819-2824
35. Regad T., and Chelbi-Alix M. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20 (2001) 7274-7286
36. Djavani M., Lukashevich I., Sánchez A., Nichol S., and Salvato M. Completion of the Lassa fever virus sequence and identification of a RING finger open frame at the L RNA 5 end. Virology 235 (1997) 414-418
37. Djavani M., Rodas J., Lukashevich I., Horejsh D., Pandolfi P., Borden K., and Salvato M. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J. Virol. (2001) 6204-6208
38. Salvato M., and Rai K. Arenaviruses. In: Collier L., and Mahy B. (Eds). Topley and Wilson's microbiology and microbial infections. ninth ed. (1997), Arnold, London, United Kingdom